Chronic disease patients (cancer, arthritis, cardiovascular diseases) undergo long-term
systemic drug treatment. Membrane transporters in ocular barriers could falsely recognize …

Simple Summary The study's purpose was to determine whether neurotoxic signs in breast
cancer patients receiving taxane (paclitaxel) chemotherapy correlate with retinal or corneal …

Purpose Anti-inflammation is essential for dry eye disease. Traditional anti-inflammation
agent corticosteroids applied in dry eye disease (DED) treatment could result in high …

The existing drugs for benign prostatic hyperplasia (BPH) are partially effective with
undesirable side-effects; hence new agents acting by different mechanism (s) are required …

Bilateral macular oedema is an uncommon side‐effect of paclitaxel administration in
oncological patients. We report the case of a 64‐year‐old man who presented with …

Abstract Non-graft-vs.-host disease (non-GVHD) ocular complications are generally
uncommon after hematopoietic cell transplantation (HCT), but can cause prolonged …

This article provides a practical review of the diagnosis and management of angle closure
induced by psychotropic agents, including tricyclic antidepressants, antipsychotics and …

Aldose reductase, although identified initially as a glucose-reducing enzyme via polyol
pathway, is believed to be an important component of antioxidant defense system as well as …

The authors experienced two cases of hydrochlorothiazide (HCTZ)-induced acute-onset
bilateral myopia and shallowing of the anterior chambers. Two middle-aged women taking …

The DNA alkylating agent busulfan is used to 'precondition'patients with leukemia,
lymphomas and other hematological disorders prior to hematopoietic stem cell transplants …